ZE94-0605
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZE94-0605, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts. [Phase 1]